Development of a cancer cells self-activating and miR-125a-5p expressing poly-pharmacological nanodrug for cancer treatment

Cancer cells can acquire resistance to targeted therapeutic agents when the designated targets or their downstream signaling molecules develop protein conformational or activity changes. There is an increasing interest in developing poly-pharmacologic anticancer agents to target multiple oncoprotein...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yung-Chieh, Shieh, Min-Chieh, Chang, Yen-Hsuan, Huang, Wei-Lun, Su, Wu-Chou, Cheng, Fong-Yu, Cheung, Chun Hei Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239037/
https://www.ncbi.nlm.nih.gov/pubmed/35703361
http://dx.doi.org/10.3892/ijmm.2022.5158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239037/
https://www.ncbi.nlm.nih.gov/pubmed/35703361
http://dx.doi.org/10.3892/ijmm.2022.5158

Ejemplares similares